References
- Algoodkar, S., Kidangazhiathmana, A., Rejani, P. P., & Shaji, K. S. (2017). Prevalence and factors associated with depression among clinically stable people living with HIV/AIDS on antiretroviral therapy. Indian Journal of Psychological Medicine, 39(6), 789–793. https://doi.org/10.4103/IJPSYM.IJPSYM_364_17
- Amanor-Boadu, S., Hipolito, M. S., Rai, N., McLean, C. K., Flanagan, K., Hamilton, F. T., Oji, V., Lambert, S. F., Le, H. N., Kapetanovic, S., & Nwulia, E. A. (2016). Poor CD4 count is a predictor of untreated depression in human immunodeficiency virus-positive African-Americans. World Journal of Psychiatry, 6(1), 128–135. https://doi.org/10.5498/wjp.v6.i1.128
- Berger-Greenstein, J. A., Cuevas, C. A., Brady, S. M., Trezza, G., Richardson, M. A., & Keane, T. M. (2007). Major depression in patients with HIV/AIDS and substance abuse. AIDS Patient Care and STDs, 21(12), 942–955. https://doi.org/10.1089/apc.2006.0153
- Binford, M. C., Kahana, S. Y., & Altice, F. L. (2012). A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Current HIV/AIDS Reports, 9(4), 287–312. https://doi.org/10.1007/s11904-012-0134-8
- Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., Turner, B. J., Eggan, F., Beckman, R., Vitiello, B., Morton, S. C., Orlando, M., Bozzette, S. A., Ortiz-Barron, L., & Shapiro, M. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58(8), 721–728. https://doi.org/10.1001/archpsyc.58.8.721
- Chichetto, N. E., Kundu, S., Freiberg, M. S., Butt, A. A., Crystal, S., So-Armah, K. A., Cook, R. L., Braithwaite, R. S., Fiellin, D. A., Khan, M. R., Bryant, K. J., Gaither, J. R., Barve, S. S., Crothers, K., Bedimo, R. J., Warner, A. L., & Tindle, H. A. (2019). Association of syndemic unhealthy alcohol use, cigarette use, and depression with all-cause mortality among adults living with and without HIV infection: Veterans aging cohort study. Open Forum Infectious Diseases, 6(6), ofz188. https://doi.org/10.1093/ofid/ofz188
- Cook, J. A., Grey, D., Burke, J., Cohen, M. H., Gurtman, A. C., Richardson, J. L., Wilson, T. E., Young, M. A., & Hessol, N. A. (2004). Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. American Journal of Public Health, 94(7), 1133–1140. https://doi.org/10.2105/AJPH.94.7.1133
- Deshmukh, N. N., Borkar, A. M., & Deshmukh, J. S. (2017). Depression and its associated factors among people living with HIV/AIDS: Can it affect their quality of life? Journal of Family Medicine and Primary Care, 6(3), 549–553. https://doi.org/10.4103/2249-4863.222016
- Do, A. N., Rosenberg, E. S., Sullivan, P. S., Beer, L., Strine, T. W., Schulden, J. D., Fagan, J. L., Freedman, M. S., Skarbinski, J., & Zheng, J. C. (2014). Excess burden of depression among HIV-infected persons receiving medical care in the United States: Data from the medical monitoring project and the behavioral risk factor surveillance system. PLoS One, 9(3), e92842. https://doi.org/10.1371/journal.pone.0092842
- Druyts, E. F., Yip, B., Lima, V. D., Burke, T. A., Lesovski, D., Fernandes, K. A., McInnes, C. W., Rustad, C. A., Montaner, J. S. G., & Hogg, R. S. (2009). Health care services utilization stratified by virological and immunological markers of HIV: Evidence from a universal health care setting. HIV Medicine, 10(2), 88–93. https://doi.org/10.1111/j.1468-1293.2008.00656.x
- Fojo, A. T., Lesko, C. R., Calkins, K. L., Moore, R. D., McCaul, M. E., Hutton, H. E., Mathews, W. C., Crane, H., Christopoulos, K., Cropsey, K., Mugavero, M. J., Mayer, K., Pence, B. W., Lau, B., & Chander, G. (2019). Do symptoms of depression interact with substance use to affect HIV continuum of care outcomes? AIDS and Behavior, 23(3), 580–591. https://doi.org/10.1007/s10461-018-2269-0
- Gutierrez, F., Garcia, L., Padilla, S., Alvarez, D., Moreno, S., Navarro, G., Gómez-Sirvent, J. L., Vidal, F., Asensi, V., & Masiá, M. (2014). Risk of clinically significant depression in HIV-infected patients: Effect of antiretroviral drugs. HIV Medicine, 15(4), 213–223. https://doi.org/10.1111/hiv.12104
- Journot, V., Chene, G., De Castro, N., Rancinan, C., Cassuto, J. P., Allard, C., Vilde, J.-L., Sobel, A., Garre, M., & Molina, J.-M. (2006). Use of efavirenz is not associated with a higher risk of depressive disorders: A substudy of the randomized clinical trial ALIZE-ANRS 099. Clinical Infectious Diseases, 42(12), 1790–1799. https://doi.org/10.1086/504323
- Kenedi, C. A., & Goforth, H. W. (2011). A systematic review of the psychiatric side-effects of efavirenz. AIDS and Behavior, 15(8), 1803–1818. https://doi.org/10.1007/s10461-011-9939-5
- Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 593–602. https://doi.org/10.1001/archpsyc.62.6.593
- Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
- Lima, V. D., Geller, J., Bangsberg, D. R., Patterson, T. L., Daniel, M., Kerr, T., Montaner, J. S., & Hogg, R. S. (2007). The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS, 21(9), 1175–1183. https://doi.org/10.1097/QAD.0b013e32811ebf57
- Metsch, L. R., Bell, C., Pereyra, M., Cardenas, G., Sullivan, T., Rodriguez, A., Gooden, L., Khoury, N., Kuper, T., Brewer, T., & del Rio, C. (2009). Hospitalized HIV-infected patients in the era of highly active antiretroviral therapy. American Journal of Public Health, 99(6), 1045–1049. https://doi.org/10.2105/AJPH.2008.139931
- Mollan, K. R., Smurzynski, M., Eron, J. J., Daar, E. S., Campbell, T. B., Sax, P. E., Gulick, R. M., Na, L., O'Keefe, L., Robertson, K. R., & Tierney, C. (2014). Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: An analysis of trial data. Annals of Internal Medicine, 161(1), 1–10. https://doi.org/10.7326/M14-0293
- Moore, J., Schuman, P., Schoenbaum, E., Boland, B., Solomon, L., & Smith, D. (1999). Severe adverse life events and depressive symptoms among women with, or at risk for, HIV infection in four cities in the United States of America. AIDS, 13(17), 2459–2468. https://doi.org/10.1097/00002030-199912030-00018
- Nanni, M. G., Caruso, R., Mitchell, A. J., Meggiolaro, E., & Grassi, L. (2015). Depression in HIV infected patients: A review. Current Psychiatry Reports, 17(1), 530. https://doi.org/10.1007/s11920-014-0530-4
- O’Cleirigh, C., Skeer, M., Mayer, K. H., & Safren, S. A. (2009). Functional impairment and health care utilization among HIV-infected men who have sex with men: The relationship with depression and post-traumatic stress. Journal of Behavioral Medicine, 32(5), 466–477. https://doi.org/10.1007/s10865-009-9217-4
- Olisah, V. O., Adekeye, O., & Sheikh, T. L. (2015). Depression and CD4 cell count among patients with HIV in a Nigerian University Teaching Hospital. The International Journal of Psychiatry in Medicine, 48(4), 253–261. https://doi.org/10.2190/PM.48.4.b
- Pence, B. W., Gaynes, B. N., Adams, J. L., Thielman, N. M., Heine, A. D., Mugavero, M. J., McGuinness, T., Raper, J. L., Willig, J. H., Shirey, K. G., Ogle, M., Turner, E. L., & Quinlivan, E. B. (2015). The effect of antidepressant treatment on HIV and depression outcomes: Results from a randomized trial. AIDS, 29(15), 1975–1986. https://doi.org/10.1097/QAD.0000000000000797
- Pence, B. W., Gaynes, B. N., Whetten, K., Eron, J. J., Jr., Ryder, R. W., & Miller, W. C. (2005). Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients. JAIDS Journal of Acquired Immune Deficiency Syndromes, 40(4), 434–444. https://doi.org/10.1097/01.qai.0000177512.30576.9c
- Pence, B. W., Mills, J. C., Bengtson, A. M., Gaynes, B. N., Breger, T. L., Cook, R. L., Moore, R. D., Grelotti, D. J., O’Cleirigh, C., & Mugavero, M. J. (2018). Association of increased chronicity of depression with HIV appointment attendance, treatment failure, and mortality among HIV-infected adults in the United States. JAMA Psychiatry, 75(4), 379–385. https://doi.org/10.1001/jamapsychiatry.2017.4726
- Prasithsirikul, W., Chongthawonsatid, S., Ohata, P. J., Keadpudsa, S., Klinbuayaem, V., Rerksirikul, P., Kerr, S. J., Ruxrungtham, K., Ananworanich, J., & Avihingsanon, A. (2017). Depression and anxiety were low amongst virally suppressed, long-term treated HIV-infected individuals enrolled in a public sector antiretroviral program in Thailand. AIDS Care, 29(3), 299–305. https://doi.org/10.1080/09540121.2016.1201194
- Sin, N. L., & DiMatteo, M. R. (2014). Depression treatment enhances adherence to antiretroviral therapy: A meta-analysis. Annals of Behavioral Medicine, 47(3), 259–269. https://doi.org/10.1007/s12160-013-9559-6
- Siu, A. L., Bibbins-Domingo, K., Grossman, D. C., Baumann, L. C., Davidson, K. W., Ebell, M., García, F. A. R., Gillman, M., Herzstein, J., Kemper, A. R., Krist, A. H., Kurth, A. E., Owens, D. K., Phillips, W. R., Phipps, M. G., & Pignone, M. P. (2016). Screening for depression in adults: US preventive services task force recommendation statement. JAMA, 315(4), 380–387. https://doi.org/10.1001/jama.2015.18392
- Tao, J., Vermund, S. H., & Qian, H. Z. (2017). Association between depression and antiretroviral therapy use among people living with HIV: A meta-analysis. AIDS and Behavior. https://doi.org/10.1007/s10461-017-1776-8
- Walkup, J., Wei, W., Sambamoorthi, U., & Crystal, S. (2008). Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression. Psychiatric Quarterly, 79(1), 43–53. https://doi.org/10.1007/s11126-007-9055-x
- Yeneabat, T., Bedaso, A., & Amare, T. (2017). Factors associated with depressive symptoms in people living with HIV attending antiretroviral clinic at Fitche Zonal Hospital, Central Ethiopia: Cross-sectional study conducted in 2012. Neuropsychiatric Disease and Treatment, 13, 2125–2131. https://doi.org/10.2147/NDT.S131722
- Yun, L. W., Maravi, M., Kobayashi, J. S., Barton, P. L., & Davidson, A. J. (2005). Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. JAIDS Journal of Acquired Immune Deficiency Syndromes, 38(4), 432–438. https://doi.org/10.1097/01.qai.0000147524.19122.fd